Literature DB >> 8747109

Glomerular and tubular function in glycogen storage disease.

P J Lee1, R N Dalton, V Shah, P C Hindmarsh, J V Leonard.   

Abstract

Urinary protein and calcium excretion were assessed in 77 patients with the hepatic glycogen storage diseases (GSD): 30 with GSD-I (median age 12.4 years, range 3.2-32.9 years), 25 with GSD-III (median age 10.5 years, range 4.2-31.3 years) and 22 with GSD-IX (median age 11.8 years, range 1.2-35.4 years). Inulin (Cinulin) and para-aminohippuric acid (CPAH) clearances were also measured in 33 of these patients. Those with GSD-I had significantly greater albumin (F = 15.07, P < 0.001), retinol-binding protein (RBP) (F = 14.66, P < 0.001), N-acetyl-beta-D-glucosaminidase (NAG) (F = 9.41, P < 0.001) and calcium (F = 7.41, P = 0.001) excretion than those with GSD-III and GSD-IX. GSD-I patients (n = 18) also had significantly higher Cinulin (F = 5.57, P = 0.009), but CPAH did not differ (F = 0.77, NS). Renal function was normal in GSD-III and GSD-IX patients. In GSD-I, Cinulin (r = -0.51, P = 0.03) and NAG excretion (r = -0.40, P = 0.03) were inversely correlated with age, whereas albumin excretion was positively correlated with age (r = +0.41, P = 0.03). RBP and calcium excretion were generally high throughout all age groups. Hyperfiltration in GSD-I is associated with renal tubular proteinuria that occurs before the onset of significant albuminuria. Deficiency of glucose-6-phosphatase within the proximal renal tubule may primarily cause tubular dysfunction, glomerular hyperfiltration being a secondary phenomenon.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8747109     DOI: 10.1007/bf00868717

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  36 in total

1.  Gout and glycogen storage disease.

Authors:  H E HOLLING
Journal:  Ann Intern Med       Date:  1963-04       Impact factor: 25.391

2.  Effect of glycine and glucagon on glomerular filtration and renal metabolic rates.

Authors:  J Johannesen; M Lie; F Kiil
Journal:  Am J Physiol       Date:  1977-07

3.  Studies in type I glycogenosis of the liver. The genesis and disposition of lactate.

Authors:  A Sadeghi-Nejad; E Presente; A Binkiewicz; B Senior
Journal:  J Pediatr       Date:  1974-07       Impact factor: 4.406

4.  Report of the Second Task Force on Blood Pressure Control in Children--1987. Task Force on Blood Pressure Control in Children. National Heart, Lung, and Blood Institute, Bethesda, Maryland.

Authors: 
Journal:  Pediatrics       Date:  1987-01       Impact factor: 7.124

5.  Fanconi's syndrome with hepatorenal glycogenosis associated with phosphorylase b kinase deficiency.

Authors:  S A Sanjad; R E Kaddoura; H M Nazer; M Akhtar; N A Sakati
Journal:  Am J Dis Child       Date:  1993-09

Review 6.  Glucose-6-phosphate: a key compound in glycogenosis I and favism leading to hyper- or hypolipidaemia.

Authors:  G Schmitz; H Hohage; K Ullrich
Journal:  Eur J Pediatr       Date:  1993       Impact factor: 3.183

7.  N-acetyl-beta-glucosaminidase and beta 2-microglobulin. Their urinary excretion in patients with renal parenchymal disease.

Authors:  R L Sherman; D E Drayer; B R Leyland-Jones; M M Reidenberg
Journal:  Arch Intern Med       Date:  1983-06

8.  Inflammatory bowel disease in glycogen storage disease type Ib.

Authors:  T F Roe; D W Thomas; V Gilsanz; H Isaacs; J B Atkinson
Journal:  J Pediatr       Date:  1986-07       Impact factor: 4.406

9.  Proximal renal tubular acidosis in a child with type 1 glycogen storage disease.

Authors:  N Matsuo; Y Tsuchiya; H Cho; T Nagai; A Tsuji
Journal:  Acta Paediatr Scand       Date:  1986-03

10.  Serum Lp(a) lipoprotein concentrations in insulin dependent diabetic patients with microalbuminuria.

Authors:  H Kapelrud; H J Bangstad; K Dahl-Jørgensen; K Berg; K F Hanssen
Journal:  BMJ       Date:  1991-09-21
View more
  13 in total

Review 1.  Dietary dilemmas in the management of glycogen storage disease type I.

Authors:  Kaustuv Bhattacharya
Journal:  J Inherit Metab Dis       Date:  2011-04-14       Impact factor: 4.982

2.  Renal sonographic findings of type I glycogen storage disease in infancy and early childhood.

Authors:  Chun-Chen Lin; Jeng-Daw Tsai; Shuan-Pei Lin; Hung-Chang Lee
Journal:  Pediatr Radiol       Date:  2005-05-19

3.  Glycogen storage disease type Ia: frequency and clinical course in Turkish children.

Authors:  I N Saltik; H Ozen; G Ciliv; N Koçak; A Yüce; F Gürakan; G Dinler
Journal:  Indian J Pediatr       Date:  2000-07       Impact factor: 1.967

4.  Targeted deletion of kidney glucose-6 phosphatase leads to nephropathy.

Authors:  Julie Clar; Blandine Gri; Julien Calderaro; Marie-Christine Birling; Yann Hérault; G Peter A Smit; Gilles Mithieux; Fabienne Rajas
Journal:  Kidney Int       Date:  2014-04-09       Impact factor: 10.612

5.  Short-term effect of captopril on microalbuminuria in children with glycogen storage disease type Ia.

Authors:  H Ozen; G Ciliv; N Koçak; I N Saltik; A Yüce; F Gürakan
Journal:  J Inherit Metab Dis       Date:  2000-07       Impact factor: 4.982

6.  Glycogen Storage Disease type 1a - a secondary cause for hyperlipidemia: report of five cases.

Authors:  Patrícia Margarida Serra Carvalho; Nuno José Marques Mendes Silva; Patrícia Glória Dinis Dias; João Filipe Cordeiro Porto; Lèlita Conceição Santos; José Manuel Nascimento Costa
Journal:  J Diabetes Metab Disord       Date:  2013-06-06

7.  A novel starch for the treatment of glycogen storage diseases.

Authors:  K Bhattacharya; R C Orton; X Qi; H Mundy; D W Morley; M P Champion; S Eaton; R F Tester; P J Lee
Journal:  J Inherit Metab Dis       Date:  2007-05-19       Impact factor: 4.982

8.  Transforming growth factor-beta in renal disease with glycogen storage disease I.

Authors:  Maki Urushihara; Shoji Kagami; Michinori Ito; Koji Yasutomo; Shuji Kondo; Akiko Kitamura; Akiyoshi Takahashi; Yasuhiro Kuroda
Journal:  Pediatr Nephrol       Date:  2004-04-03       Impact factor: 3.714

9.  Renal function in glycogen storage disease type I, natural course, and renopreservative effects of ACE inhibition.

Authors:  Daniëlle H J Martens; Jan Peter Rake; Gerjan Navis; Vaclav Fidler; Catharina M L van Dael; G Peter A Smit
Journal:  Clin J Am Soc Nephrol       Date:  2009-10-01       Impact factor: 8.237

Review 10.  Investigation and management of the hepatic glycogen storage diseases.

Authors:  Kaustuv Bhattacharya
Journal:  Transl Pediatr       Date:  2015-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.